Further analysis revealed that the antiviral molecule, Mx1 was significantly upregulated in K18 mice and appears to be a key innate host defense mediator in this line relative to all other groups as previously observed in critical COVID-19 patients (51). This evidence concerns the gene MX1 and COVID-19.